NovaBridge Biosciences Names Dr. Srishti Gupta CEO to Lead Clinical Development Strategy

NovaBridge Biosciences (Nasdaq: NBP) has appointed physician-executive Dr. Srishti Gupta as chief executive officer and a member of its board... Read More

The post NovaBridge Biosciences Names Dr. Srishti Gupta CEO to Lead Clinical Development Strategy appeared first on citybiz.